批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2019/05/01 |
SUPPL-40(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/03/28 |
SUPPL-38(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/08/13 |
SUPPL-36(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/08/28 |
SUPPL-28(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2005/10/07 |
SUPPL-16(补充) |
Approval |
Labeling |
|
|
|
1998/11/10 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/07/31 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/06/15 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/06/15 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1995/11/30 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1991/11/08 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1990/08/01 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1989/05/24 |
SUPPL-13(补充) |
Approval |
Labeling |
|
|
|
1988/11/30 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1987/10/29 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1986/09/29 |
SUPPL-1(补充) |
Approval |
Labeling |
|
|
|
1986/09/12 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1986/05/20 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1986/04/23 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1985/02/22 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1984/11/16 |
SUPPL-3(补充) |
Approval |
Labeling |
|
|
|
1983/12/15 |
SUPPL-2(补充) |
Approval |
Labeling |
|
|
|
1983/07/27 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:BETAMETHASONE DIPROPIONATE 剂型/给药途径:OINTMENT, AUGMENTED;TOPICAL 规格:EQ 0.05% BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
018741 |
001 |
NDA |
DIPROLENE |
BETAMETHASONE DIPROPIONATE |
OINTMENT, AUGMENTED;TOPICAL |
EQ 0.05% BASE |
Prescription |
Yes |
Yes |
AB |
1983/07/27
|
ORGANON |
074304 |
001 |
ANDA |
BETAMETHASONE DIPROPIONATE |
BETAMETHASONE DIPROPIONATE |
OINTMENT, AUGMENTED;TOPICAL |
EQ 0.05% BASE |
Prescription |
No |
No |
AB |
1995/08/31
|
ACTAVIS MID ATLANTIC |
075373 |
001 |
ANDA |
BETAMETHASONE DIPROPIONATE |
BETAMETHASONE DIPROPIONATE |
OINTMENT, AUGMENTED;TOPICAL |
EQ 0.05% BASE |
Prescription |
No |
No |
AB |
1999/06/22
|
FOUGERA PHARMS |
076753 |
001 |
ANDA |
BETAMETHASONE DIPROPIONATE |
BETAMETHASONE DIPROPIONATE |
OINTMENT, AUGMENTED;TOPICAL |
EQ 0.05% BASE |
Prescription |
No |
No |
AB |
2004/10/12
|
TARO |
206118 |
001 |
ANDA |
BETAMETHASONE DIPROPIONATE |
BETAMETHASONE DIPROPIONATE |
OINTMENT, AUGMENTED;TOPICAL |
EQ 0.05% BASE |
Discontinued |
No |
No |
AB |
2017/11/09
|
PADAGIS US |
209106 |
001 |
ANDA |
BETAMETHASONE DIPROPIONATE |
BETAMETHASONE DIPROPIONATE |
OINTMENT, AUGMENTED;TOPICAL |
EQ 0.05% BASE |
Prescription |
No |
No |
AB |
2019/12/18
|
LUPIN LTD |
218289 |
001 |
ANDA |
BETAMETHASONE DIPROPIONATE |
BETAMETHASONE DIPROPIONATE |
OINTMENT, AUGMENTED;TOPICAL |
EQ 0.05% BASE |
Prescription |
No |
No |
AB |
2024/04/10
|
AUROBINDO PHARMA LTD |